SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 247,135.77 |
| Enterprise Value ($M) | 270,740.77 |
| Book Value ($M) | 40,871.00 |
| Book Value / Share | 26.36 |
| Price / Book | 6.05 |
| NCAV ($M) | -37,337.00 |
| NCAV / Share | -24.08 |
| Price / NCAV | -6.62 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.10 |
| Return on Assets (ROA) | 0.07 |
| Return on Equity (ROE) | 0.18 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.74 |
| Current Ratio | 0.93 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 25,827.00 |
| Assets | 104,035.00 |
| Liabilities | 63,164.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 54,073.00 |
| Operating Income | 12,414.00 |
| Net Income | 7,035.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 11,861.00 |
| Cash from Investing | -7,980.00 |
| Cash from Financing | -3,996.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| AVRW – Avenir Wellness Solutions, Inc. | AVVH – AVVAA World Health Care Products, Inc. |
| AXIM – AXIM Biotechnologies, Inc. | BCHMF – Bachem Holding AG |
| BDPT – BioAdaptives, Inc. |
Financial data and stock pages provided by
Fintel.io